Mesenchymal Stromal Cells for Ischemic Stroke

Summary

The purpose of this study is to determine if mesenchymal stem cells given by IV is feasible and safe in patients with recent ischemic stroke and to decide the maximum tolerated dose when given between 3-10 days after an ischemic stroke.

Timeline

Start

2016-12

Primary completion

2018-12

Completion

2018-12

Drugs

Indications